Copyright Reports & Markets. All rights reserved.

Global Non-invasive Helicobacter Pylori Diagnostic Testing Market Insights, Forecast to 2028

Buy now

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
  • 1.2.1 Global Non-invasive Helicobacter Pylori Diagnostic Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Invasive Techniques
  • 1.2.3 Non-invasive Techniques
  • 1.3 Market by Application
  • 1.3.1 Global Non-invasive Helicobacter Pylori Diagnostic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospitals and Clinics
  • 1.3.3 Diagnostic Laboratories
  • 1.4 Study Objectives
  • 1.5 Years Considered
  • 2 Global Growth Trends

    • 2.1 Global Non-invasive Helicobacter Pylori Diagnostic Testing Market Perspective (2017-2028)
    • 2.2 Non-invasive Helicobacter Pylori Diagnostic Testing Growth Trends by Region
    • 2.2.1 Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Non-invasive Helicobacter Pylori Diagnostic Testing Historic Market Size by Region (2017-2022)
  • 2.2.3 Non-invasive Helicobacter Pylori Diagnostic Testing Forecasted Market Size by Region (2023-2028)
  • 2.3 Non-invasive Helicobacter Pylori Diagnostic Testing Market Dynamics
  • 2.3.1 Non-invasive Helicobacter Pylori Diagnostic Testing Industry Trends
  • 2.3.2 Non-invasive Helicobacter Pylori Diagnostic Testing Market Drivers
  • 2.3.3 Non-invasive Helicobacter Pylori Diagnostic Testing Market Challenges
  • 2.3.4 Non-invasive Helicobacter Pylori Diagnostic Testing Market Restraints
  • 3 Competition Landscape by Key Players

    • 3.1 Global Top Non-invasive Helicobacter Pylori Diagnostic Testing Players by Revenue
    • 3.1.1 Global Top Non-invasive Helicobacter Pylori Diagnostic Testing Players by Revenue (2017-2022)
  • 3.1.2 Global Non-invasive Helicobacter Pylori Diagnostic Testing Revenue Market Share by Players (2017-2022)
  • 3.2 Global Non-invasive Helicobacter Pylori Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Non-invasive Helicobacter Pylori Diagnostic Testing Revenue
  • 3.4 Global Non-invasive Helicobacter Pylori Diagnostic Testing Market Concentration Ratio
  • 3.4.1 Global Non-invasive Helicobacter Pylori Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Helicobacter Pylori Diagnostic Testing Revenue in 2021
  • 3.5 Non-invasive Helicobacter Pylori Diagnostic Testing Key Players Head office and Area Served
  • 3.6 Key Players Non-invasive Helicobacter Pylori Diagnostic Testing Product Solution and Service
  • 3.7 Date of Enter into Non-invasive Helicobacter Pylori Diagnostic Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans
  • 4 Non-invasive Helicobacter Pylori Diagnostic Testing Breakdown Data by Type

    • 4.1 Global Non-invasive Helicobacter Pylori Diagnostic Testing Historic Market Size by Type (2017-2022)
    • 4.2 Global Non-invasive Helicobacter Pylori Diagnostic Testing Forecasted Market Size by Type (2023-2028)

    5 Non-invasive Helicobacter Pylori Diagnostic Testing Breakdown Data by Application

    • 5.1 Global Non-invasive Helicobacter Pylori Diagnostic Testing Historic Market Size by Application (2017-2022)
    • 5.2 Global Non-invasive Helicobacter Pylori Diagnostic Testing Forecasted Market Size by Application (2023-2028)

    6 North America

    • 6.1 North America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size (2017-2028)
    • 6.2 North America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Type
    • 6.2.1 North America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Type (2017-2022)
  • 6.2.2 North America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Type (2023-2028)
  • 6.2.3 North America Non-invasive Helicobacter Pylori Diagnostic Testing Market Share by Type (2017-2028)
  • 6.3 North America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Application
  • 6.3.1 North America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Application (2017-2022)
  • 6.3.2 North America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Application (2023-2028)
  • 6.3.3 North America Non-invasive Helicobacter Pylori Diagnostic Testing Market Share by Application (2017-2028)
  • 6.4 North America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Country
  • 6.4.1 North America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Country (2017-2022)
  • 6.4.2 North America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Country (2023-2028)
  • 6.4.3 United States
  • 6.4.4 Canada
  • 7 Europe

    • 7.1 Europe Non-invasive Helicobacter Pylori Diagnostic Testing Market Size (2017-2028)
    • 7.2 Europe Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Type
    • 7.2.1 Europe Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Type (2017-2022)
  • 7.2.2 Europe Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Type (2023-2028)
  • 7.2.3 Europe Non-invasive Helicobacter Pylori Diagnostic Testing Market Share by Type (2017-2028)
  • 7.3 Europe Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Application
  • 7.3.1 Europe Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Application (2017-2022)
  • 7.3.2 Europe Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Application (2023-2028)
  • 7.3.3 Europe Non-invasive Helicobacter Pylori Diagnostic Testing Market Share by Application (2017-2028)
  • 7.4 Europe Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Country
  • 7.4.1 Europe Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Country (2017-2022)
  • 7.4.2 Europe Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries
  • 8 Asia-Pacific

    • 8.1 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Testing Market Size (2017-2028)
    • 8.2 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Type
    • 8.2.1 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Testing Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Application
  • 8.3.1 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Testing Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Region
  • 8.4.1 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia
  • 9 Latin America

    • 9.1 Latin America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size (2017-2028)
    • 9.2 Latin America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Type
    • 9.2.1 Latin America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Type (2017-2022)
  • 9.2.2 Latin America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Type (2023-2028)
  • 9.2.3 Latin America Non-invasive Helicobacter Pylori Diagnostic Testing Market Share by Type (2017-2028)
  • 9.3 Latin America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Application
  • 9.3.1 Latin America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Application (2017-2022)
  • 9.3.2 Latin America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Application (2023-2028)
  • 9.3.3 Latin America Non-invasive Helicobacter Pylori Diagnostic Testing Market Share by Application (2017-2028)
  • 9.4 Latin America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Country
  • 9.4.1 Latin America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Country (2017-2022)
  • 9.4.2 Latin America Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil
  • 10 Middle East & Africa

    • 10.1 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Testing Market Size (2017-2028)
    • 10.2 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Type
    • 10.2.1 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Testing Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Application
  • 10.3.1 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Testing Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Country
  • 10.4.1 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Non-invasive Helicobacter Pylori Diagnostic Testing Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE
  • 11 Key Players Profiles

    • 11.1 Sekisui Diagnostics
    • 11.1.1 Sekisui Diagnostics Company Details
  • 11.1.2 Sekisui Diagnostics Business Overview
  • 11.1.3 Sekisui Diagnostics Non-invasive Helicobacter Pylori Diagnostic Testing Introduction
  • 11.1.4 Sekisui Diagnostics Revenue in Non-invasive Helicobacter Pylori Diagnostic Testing Business (2017-2022)
  • 11.1.5 Sekisui Diagnostics Recent Developments
  • 11.2 F. Hoffmann-La Roche
  • 11.2.1 F. Hoffmann-La Roche Company Details
  • 11.2.2 F. Hoffmann-La Roche Business Overview
  • 11.2.3 F. Hoffmann-La Roche Non-invasive Helicobacter Pylori Diagnostic Testing Introduction
  • 11.2.4 F. Hoffmann-La Roche Revenue in Non-invasive Helicobacter Pylori Diagnostic Testing Business (2017-2022)
  • 11.2.5 F. Hoffmann-La Roche Recent Developments
  • 11.3 Medline Industries
  • 11.3.1 Medline Industries Company Details
  • 11.3.2 Medline Industries Business Overview
  • 11.3.3 Medline Industries Non-invasive Helicobacter Pylori Diagnostic Testing Introduction
  • 11.3.4 Medline Industries Revenue in Non-invasive Helicobacter Pylori Diagnostic Testing Business (2017-2022)
  • 11.3.5 Medline Industries Recent Developments
  • 11.4 Meridian Bioscience
  • 11.4.1 Meridian Bioscience Company Details
  • 11.4.2 Meridian Bioscience Business Overview
  • 11.4.3 Meridian Bioscience Non-invasive Helicobacter Pylori Diagnostic Testing Introduction
  • 11.4.4 Meridian Bioscience Revenue in Non-invasive Helicobacter Pylori Diagnostic Testing Business (2017-2022)
  • 11.4.5 Meridian Bioscience Recent Developments
  • 11.5 Bio-Rad Laboratories
  • 11.5.1 Bio-Rad Laboratories Company Details
  • 11.5.2 Bio-Rad Laboratories Business Overview
  • 11.5.3 Bio-Rad Laboratories Non-invasive Helicobacter Pylori Diagnostic Testing Introduction
  • 11.5.4 Bio-Rad Laboratories Revenue in Non-invasive Helicobacter Pylori Diagnostic Testing Business (2017-2022)
  • 11.5.5 Bio-Rad Laboratories Recent Developments
  • 11.6 Thermo Fisher Scientific
  • 11.6.1 Thermo Fisher Scientific Company Details
  • 11.6.2 Thermo Fisher Scientific Business Overview
  • 11.6.3 Thermo Fisher Scientific Non-invasive Helicobacter Pylori Diagnostic Testing Introduction
  • 11.6.4 Thermo Fisher Scientific Revenue in Non-invasive Helicobacter Pylori Diagnostic Testing Business (2017-2022)
  • 11.6.5 Thermo Fisher Scientific Recent Developments
  • 11.7 Alpha Laboratories
  • 11.7.1 Alpha Laboratories Company Details
  • 11.7.2 Alpha Laboratories Business Overview
  • 11.7.3 Alpha Laboratories Non-invasive Helicobacter Pylori Diagnostic Testing Introduction
  • 11.7.4 Alpha Laboratories Revenue in Non-invasive Helicobacter Pylori Diagnostic Testing Business (2017-2022)
  • 11.7.5 Alpha Laboratories Recent Developments
  • 11.8 EKF Diagnostics
  • 11.8.1 EKF Diagnostics Company Details
  • 11.8.2 EKF Diagnostics Business Overview
  • 11.8.3 EKF Diagnostics Non-invasive Helicobacter Pylori Diagnostic Testing Introduction
  • 11.8.4 EKF Diagnostics Revenue in Non-invasive Helicobacter Pylori Diagnostic Testing Business (2017-2022)
  • 11.8.5 EKF Diagnostics Recent Developments
  • 11.9 Quidel
  • 11.9.1 Quidel Company Details
  • 11.9.2 Quidel Business Overview
  • 11.9.3 Quidel Non-invasive Helicobacter Pylori Diagnostic Testing Introduction
  • 11.9.4 Quidel Revenue in Non-invasive Helicobacter Pylori Diagnostic Testing Business (2017-2022)
  • 11.9.5 Quidel Recent Developments
  • 11.10 Halyard Health
  • 11.10.1 Halyard Health Company Details
  • 11.10.2 Halyard Health Business Overview
  • 11.10.3 Halyard Health Non-invasive Helicobacter Pylori Diagnostic Testing Introduction
  • 11.10.4 Halyard Health Revenue in Non-invasive Helicobacter Pylori Diagnostic Testing Business (2017-2022)
  • 11.10.5 Halyard Health Recent Developments
  • 11.11 Cardinal Health
  • 11.11.1 Cardinal Health Company Details
  • 11.11.2 Cardinal Health Business Overview
  • 11.11.3 Cardinal Health Non-invasive Helicobacter Pylori Diagnostic Testing Introduction
  • 11.11.4 Cardinal Health Revenue in Non-invasive Helicobacter Pylori Diagnostic Testing Business (2017-2022)
  • 11.11.5 Cardinal Health Recent Developments
  • 11.12 Beckman Coulter
  • 11.12.1 Beckman Coulter Company Details
  • 11.12.2 Beckman Coulter Business Overview
  • 11.12.3 Beckman Coulter Non-invasive Helicobacter Pylori Diagnostic Testing Introduction
  • 11.12.4 Beckman Coulter Revenue in Non-invasive Helicobacter Pylori Diagnostic Testing Business (2017-2022)
  • 11.12.5 Beckman Coulter Recent Developments
  • 11.13 Agilent Technologies
  • 11.13.1 Agilent Technologies Company Details
  • 11.13.2 Agilent Technologies Business Overview
  • 11.13.3 Agilent Technologies Non-invasive Helicobacter Pylori Diagnostic Testing Introduction
  • 11.13.4 Agilent Technologies Revenue in Non-invasive Helicobacter Pylori Diagnostic Testing Business (2017-2022)
  • 11.13.5 Agilent Technologies Recent Developments
  • 11.14 Coris BioConcept
  • 11.14.1 Coris BioConcept Company Details
  • 11.14.2 Coris BioConcept Business Overview
  • 11.14.3 Coris BioConcept Non-invasive Helicobacter Pylori Diagnostic Testing Introduction
  • 11.14.4 Coris BioConcept Revenue in Non-invasive Helicobacter Pylori Diagnostic Testing Business (2017-2022)
  • 11.14.5 Coris BioConcept Recent Developments
  • 12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
    • 13.2 Author Details
    • Market Analysis and Insights: Global Non-invasive Helicobacter Pylori Diagnostic Testing Market
      The global Non-invasive Helicobacter Pylori Diagnostic Testing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

      Fully considering the economic change by this health crisis, Invasive Techniques accounting for % of the Non-invasive Helicobacter Pylori Diagnostic Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals and Clinics segment is altered to an % CAGR throughout this forecast period.

      China Non-invasive Helicobacter Pylori Diagnostic Testing market size is valued at US$ million in 2021, while the North America and Europe Non-invasive Helicobacter Pylori Diagnostic Testing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Non-invasive Helicobacter Pylori Diagnostic Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

      With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-invasive Helicobacter Pylori Diagnostic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-invasive Helicobacter Pylori Diagnostic Testing market in terms of revenue.

      Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-invasive Helicobacter Pylori Diagnostic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-invasive Helicobacter Pylori Diagnostic Testing market.

      Impact of Covid-19 Outbreak

      This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

      Segmental Analysis

      The report has been segmented into product and application segments. The researchers have documented all the products present today in the Non-invasive Helicobacter Pylori Diagnostic Testing market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

      Non-invasive Helicobacter Pylori Diagnostic Testing Breakdown Data by Type

      Invasive Techniques

      Non-invasive Techniques

      Non-invasive Helicobacter Pylori Diagnostic Testing Breakdown Data by Application

      Hospitals and Clinics

      Diagnostic Laboratories

      By Region

      North America

      United States

      Canada

      Europe

      Germany

      France

      UK

      Italy

      Russia

      Nordic Countries

      Rest of Europe

      Asia-Pacific

      China

      Japan

      South Korea

      Southeast Asia

      India

      Australia

      Rest of Asia

      Latin America

      Mexico

      Brazil

      Rest of Latin America

      Middle East & Africa

      Turkey

      Saudi Arabia

      UAE

      Rest of MEA

      Competitive Landscape

      This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

      Sekisui Diagnostics

      F. Hoffmann-La Roche

      Medline Industries

      Meridian Bioscience

      Bio-Rad Laboratories

      Thermo Fisher Scientific

      Alpha Laboratories

      EKF Diagnostics

      Quidel

      Halyard Health

      Cardinal Health

      Beckman Coulter

      Agilent Technologies

      Coris BioConcept

      Frequently Asked Questions

      What factors will challenge the Non-invasive Helicobacter Pylori Diagnostic Testing market growth?

      Which end-use segment will expand at the fastest CAGR in the Non-invasive Helicobacter Pylori Diagnostic Testing market?

      Which are the emerging players in the Non-invasive Helicobacter Pylori Diagnostic Testing market?

      How concentrated is the Non-invasive Helicobacter Pylori Diagnostic Testing market?

      Which factors are positively contributing to the Non-invasive Helicobacter Pylori Diagnostic Testing market growth?

      Which are the novel product innovations in the Non-invasive Helicobacter Pylori Diagnostic Testing market?

      Which product segment will emerge as the most lucrative in the Non-invasive Helicobacter Pylori Diagnostic Testing market?

      Which factors are increasing the competition in the Non-invasive Helicobacter Pylori Diagnostic Testing market?

      Which are the strategic measures taken by the Non-invasive Helicobacter Pylori Diagnostic Testing industry players?

      Which region will witness inactive growth during the forecast period?

      What key trends are likely to emerge in the Non-invasive Helicobacter Pylori Diagnostic Testing market in the coming years?

      Buy now